NCT01102998

Brief Summary

Survivors of pediatric brain tumors are noted to have increased rates of excessive daytime sleepiness. However, very little data are available regarding the specific sleep disturbances of pediatric brain tumor survivors. Children ages 8 to 18 years of age who are at least 5 years from diagnosis and at least 2 years post treatment or observation only for a brain tumor will be targeted to assess the prevalence of sleep complaints. The study focuses on the following objectives:

  • To estimate sleep disturbance in a cohort of pediatric brain tumor survivors.
  • Estimate the rates of parent- and self-reported excessive daytime sleepiness in pediatric brain tumors
  • Estimate the rates of parent-reported sleep-disordered breathing, including snoring and witnessed apneas, in pediatric brain tumor survivors
  • Estimate the rates of parent- and self-reported behavioral sleep problems, including nocturnal enuresis, bedtime resistance, nighttime awakenings, nightmares, and fatigue in pediatric brain tumor survivors. The Study focuses on the following secondary objectives:
  • To describe bedtime patterns and sleep hygiene of pediatric brain tumor survivors.
  • Estimate the typical parent- and self-reported weekday sleep duration of pediatric brain tumor survivors
  • Estimate the typical parent- and self-reported weekend sleep duration of pediatric brain tumor survivors and if it differs from the weekday sleep duration
  • Estimate the typical parent- and self-reported consistency of sleep hygiene in pediatric brain tumor survivors

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 13, 2010

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2012

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

November 18, 2013

Status Verified

November 1, 2013

Enrollment Period

2.4 years

First QC Date

April 12, 2010

Last Update Submit

November 15, 2013

Conditions

Keywords

Sleep complaintsBrain Tumor Survivors

Outcome Measures

Primary Outcomes (1)

  • Sleep disturbance in a cohort of pediatric brain tumor survivors.

    * Estimate the rates of parent- and self-reported excessive daytime sleepiness in pediatric brain tumors * Estimate the rates of parent-reported sleep-disordered breathing, including snoring and witnessed apneas, in pediatric brain tumor survivors * Estimate the rates of parent- and self-reported behavioral sleep problems, including nocturnal enuresis, bedtime resistance, nighttime awakenings, nightmares, and fatigue in pediatric brain tumor survivors.

    2 years

Study Arms (1)

Brain Tumor Survivors

Brain tumor survivors ages 8 to 18 years who are at least 5 years post diagnosis and at least 2 years post active therapy or observation and their parents/guardians will be approached to participate during clinic visits.

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children ages 8 to 18 years of age who are patients at St Jude Children's Research Hospital and are at least 5 years from diagnosis and at least 2 years post treatment or observation only for a brain tumor were targeted to assess the prevalence of sleep complaints.

You may qualify if:

  • Age ≥8 to ≤ 18 years of age
  • Brain tumor survivor
  • ≥5 years post diagnosis
  • ≥2 years post active cancer-directed therapy or observation only
  • Parents speak and read English fluently
  • Potential participant reads English fluently
  • Potential participant/guardian willing to sign consent

You may not qualify if:

  • Survivor of any cancer other than a brain tumor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St . Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

Related Links

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Valerie Crabtree, Ph.D

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2010

First Posted

April 13, 2010

Study Start

April 1, 2010

Primary Completion

September 1, 2012

Study Completion

April 1, 2013

Last Updated

November 18, 2013

Record last verified: 2013-11

Locations